Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
Letian Song, Shenghua Gao, Bing Ye, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 87-109
Open Access | Times Cited: 19

Showing 19 citing articles:

Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives
Andrea Citarella, Alessandro Dimasi, Davide Moi, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1339-1339
Open Access | Times Cited: 26
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents
Agnieszka Zagórska, Anna Czopek, Monika Fryc, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 797-797
Open Access | Times Cited: 8
Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review
Ya-Qi Xiao, Jiao Long, Shuang‐Shuang Zhang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107380-107380
Closed Access | Times Cited: 7
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
Shenghua Gao, Letian Song, Katharina Sylvester, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16426-16440
Closed Access | Times Cited: 14
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 5
Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies
Dóra Laczi, Sofia Schönbauer Huamán, Taylah Andrews-Clark, et al.
European Journal of Medicinal Chemistry (2025), pp. 117603-117603
Open Access
Miniaturized Modular Click Chemistry‐enabled Rapid Discovery of Unique SARS‐CoV‐2 Mpro Inhibitors With Robust Potency and Drug‐like Profile
Mianling Yang, Myoung Kyu Lee, Shenghua Gao, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice
Mianling Yang, Meehyein Kim, Peng Zhan
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4189-4192
Open Access | Times Cited: 2
Asymmetric imidazole-4,5-dicarboxamides derivatives as SARS-CoV-2 main protease inhibitors: Design, Synthesis and Biological Evaluation
P. Huynh, Phatcharin Khamplong, Minh-Hoang Phan, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
The S2 Pocket Governs the Genus‐Specific Substrate Selectivity of Coronavirus 3C‐Like Protease
Yanrong Zhou, Peng Sun, Zhixiang Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 44
Open Access | Times Cited: 1
In Silico Development of SARS-CoV-2 Non-covalent Mpro Inhibitors: A Review
Islam Alagawani, Feng Wang
(2024)
Open Access | Times Cited: 1
High-throughput modular click chemistry synthesis of catechol derivatives as covalent inhibitors of SARS-CoV-2 3CLpro
Feng Wang, Tiancheng Ma, Donglan Liu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
De Novo Discovery of a Noncovalent Cell-Penetrating Bicyclic Peptide Inhibitor Targeting SARS-CoV-2 Main Protease
Yahong Tan, Jinyue Yang, Min Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20258-20274
Closed Access | Times Cited: 1
De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes
Yan Zhu, Jiaolong Meng, Bo Feng, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1327-1334.e3
Closed Access
(Z)-N-Carbamoyl-4-hydroxy-4-(4-methoxyphenyl)-2-oxobut-3-enamide
Alexandra O. Derevnina, Anastasia A. Andreeva, А. Н. Масливец
Molbank (2024) Vol. 2024, Iss. 3, pp. M1844-M1844
Open Access
Viral Protein Dimerization Quality Control: A Design Strategy for a Potential Viral Inhibitor
Shaoqing Du, Xinyong Liu, Xueping Hu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CLpro) inhibitors with anti-coronavirus activities
Fan Pan, Qifan Zhou, Ming Yan, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107988-107988
Closed Access
ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning
Mingyang Wang, Shuai Li, Jike Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Ultrasensitive Chemiluminescence Probes Designed from Covalent Inhibitors for SRAS-CoV-2 Mpro Detection
Suping Xia, En Liang, Lin Xu, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 49, pp. 19641-19650
Closed Access
Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration
Heng Zhang, Jing Li, Károly Tóth, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117531-117531
Closed Access
Page 1

Scroll to top